285 related articles for article (PubMed ID: 4765368)
21. Protection by immune spleen cells against challenge with Moloney sarcoma virus. Effect of stage of donor response.
Pollack S; Nelson K
Transplantation; 1973 May; 15(5):510-3. PubMed ID: 4710486
[No Abstract] [Full Text] [Related]
22. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
Mortensen RF
J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
[No Abstract] [Full Text] [Related]
23. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. I. Influence of neonatal infection with the mammary tumor virus on the growth of spontaneous mammary adenocarcinomas.
Morton DL
J Natl Cancer Inst; 1969 Feb; 42(2):311-20. PubMed ID: 4303883
[No Abstract] [Full Text] [Related]
24. Antigen driven selection for Fc receptors of enhancing antibody on macrophages during an alloimmune response.
Whitten HD; Cruse JM; Lewis GK; Watson ES
J Reticuloendothel Soc; 1974 Feb; 15(2):118-25. PubMed ID: 4815211
[No Abstract] [Full Text] [Related]
25. Tumor-specific transplantation immunity after cryosurgery.
Myers RS; Hammond WG; Ketcham AS
J Surg Oncol; 1969; 1(3):241-6. PubMed ID: 5406367
[No Abstract] [Full Text] [Related]
26. Radiation-induced changes in established tumor immunity.
Vaage J; Doroshow JH; DuBois TT
Cancer Res; 1974 Jan; 34(1):129-37. PubMed ID: 4809453
[No Abstract] [Full Text] [Related]
27. In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
Iglehart JD; Ward EC; Huper G; Thiel K; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):117-22. PubMed ID: 6942182
[TBL] [Abstract][Full Text] [Related]
28. The immunogenic activity of tumor antigens retained by the reticuloendothelial cells of tumor-bearing mice.
Vaage J
Cancer Res; 1972 May; 32(5):898-903. PubMed ID: 5017740
[No Abstract] [Full Text] [Related]
29. Inhibition of tumor growth and survival of aged mice inoculated with Moloney tumor transplants and treated with endotoxin.
Strausser HR; Bober LA
Cancer Res; 1972 Oct; 32(10):2156-9. PubMed ID: 4562825
[No Abstract] [Full Text] [Related]
30. Protective serum effects in tumor immunity.
Vaage J
Isr J Med Sci; 1976; 12(4-5):334-43. PubMed ID: 939693
[TBL] [Abstract][Full Text] [Related]
31. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
Rouse BT; Wagner H; Harris AW
J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
[No Abstract] [Full Text] [Related]
32. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
[No Abstract] [Full Text] [Related]
33. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
Rios A; Simmons RL
Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
[No Abstract] [Full Text] [Related]
34. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
Vaage J; Jones RD; Brown BW
Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
[No Abstract] [Full Text] [Related]
35. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
Tamerius JD; Hellström I
J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
[No Abstract] [Full Text] [Related]
36. Immunologic enhancement in a syngeneic tumor system.
Beltz WR; Levy NL
Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
[No Abstract] [Full Text] [Related]
37. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
38. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
Bendre AR; Gangal SG
Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
[No Abstract] [Full Text] [Related]
39. [Tumor immunity induced by local radiotherapy].
Yamashita T; Hayakawa Y; Hanajima K; Mochizuki S
Gan No Rinsho; 1983 Oct; 29(13):1506-11. PubMed ID: 6422094
[TBL] [Abstract][Full Text] [Related]
40. Immunologic aspects of tumor induction by mammary tumor virus.
Blair PB
J Natl Cancer Inst; 1972 Apr; 48(4):1121-4. PubMed ID: 4336876
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
